Literature DB >> 10905472

Fuel selection in human skeletal muscle in insulin resistance: a reexamination.

D E Kelley1, L J Mandarino.   

Abstract

For many years, the Randle glucose fatty acid cycle has been invoked to explain insulin resistance in skeletal muscle of patients with type 2 diabetes or obesity. Increased fat oxidation was hypothesized to reduce glucose metabolism. The results of a number of investigations have shown that artificially increasing fat oxidation by provision of excess lipid does decrease glucose oxidation in the whole body. However, results obtained with rodent or human systems that more directly examined muscle fuel selection have found that skeletal muscle in insulin resistance is accompanied by increased, rather than decreased, muscle glucose oxidation under basal conditions and decreased glucose oxidation under insulin-stimulated circumstances, producing a state of "metabolic inflexibility." Such a situation could contribute to the accumulation of triglyceride within the myocyte, as has been observed in insulin resistance. Recent knowledge of insulin receptor signaling indicates that the accumulation of lipid products in muscle can interfere with insulin signaling and produce insulin resistance. Therefore, although the Randle cycle is a valid physiological principle, it may not explain insulin resistance in skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10905472     DOI: 10.2337/diabetes.49.5.677

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  293 in total

1.  Measuring mitochondrial respiration in intact single muscle fibers.

Authors:  Rosemary A Schuh; Kathryn C Jackson; Ramzi J Khairallah; Christopher W Ward; Espen E Spangenburg
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-07       Impact factor: 3.619

2.  Validation of a novel index to assess insulin resistance of adipose tissue lipolytic activity in obese subjects.

Authors:  Elisa Fabbrini; Faidon Magkos; Caterina Conte; Bettina Mittendorfer; Bruce W Patterson; Adewole L Okunade; Samuel Klein
Journal:  J Lipid Res       Date:  2011-12-05       Impact factor: 5.922

3.  Hyperglycemia and oxidative stress: complex relationships with attractive prospects.

Authors:  Xavier Leverve
Journal:  Intensive Care Med       Date:  2003-04       Impact factor: 17.440

Review 4.  Peroxisome proliferator activated receptors, fatty acids and muscle insulin resistance.

Authors:  Edward Kraegen; Gregory Cooney; Ji-Ming Ye; Stuart Furler
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

5.  Impaired beta-adrenergically mediated lipolysis in skeletal muscle of obese subjects.

Authors:  E E Blaak; S L Schiffelers; W H Saris; M Mensink; M E Kooi
Journal:  Diabetologia       Date:  2004-07-28       Impact factor: 10.122

6.  GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization.

Authors:  Ko Kotani; Odile D Peroni; Yasuhiko Minokoshi; Olivier Boss; Barbara B Kahn
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

Review 7.  Role of ACE inhibitors in treating hypertensive diabetic patients.

Authors:  Dmitri Kirpichnikov; James R Sowers
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

8.  Effect of exercise training on muscle glucose transporter 4 protein and intramuscular lipid content in elderly men with impaired glucose tolerance.

Authors:  Hyo Jeong Kim; Jong Sam Lee; Chang Keun Kim
Journal:  Eur J Appl Physiol       Date:  2004-12       Impact factor: 3.078

9.  Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning.

Authors:  Ram Weiss; Sylvie Dufour; Sara E Taksali; William V Tamborlane; Kitt F Petersen; Riccardo C Bonadonna; Linda Boselli; Gina Barbetta; Karin Allen; Francis Rife; Mary Savoye; James Dziura; Robert Sherwin; Gerald I Shulman; Sonia Caprio
Journal:  Lancet       Date:  2003-09-20       Impact factor: 79.321

10.  Plasma acylcarnitines during insulin stimulation in humans are reflective of age-related metabolic dysfunction.

Authors:  Leslie A Consitt; Timothy R Koves; Deborah M Muoio; Masato Nakazawa; Christopher A Newton; Joseph A Houmard
Journal:  Biochem Biophys Res Commun       Date:  2016-09-28       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.